NCT04353336View on ClinicalTrials.gov

Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

March 23, 2020

Primary Completion Date

June 1, 2020

Study Completion Date

July 1, 2020

Conditions
COVID-19Coronavirus Infection
Interventions
DRUG

Chloroquine or Hydroxychloroquine

Chloroquine or Hydroxychloroquine

Trial Locations (1)

35111

Tanta University, Assiut University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT04353336 - Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment | Biotech Hunter | Biotech Hunter